Mizuho Maintains Buy on Encompass Health, Raises Price Target to $82-Report released on 8th February 2024
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Ann Hynes maintains a Buy rating on Encompass Health (NYSE:EHC) and raises the price target from $77 to $82 as of 8th February 2024.

February 09, 2024 | 3:49 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Mizuho analyst Ann Hynes maintains a Buy rating on Encompass Health and raises the price target from $77 to $82.
The increase in price target by Mizuho reflects a positive outlook on Encompass Health's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100